secwatch.observer — SEC 8-K summary
======================================

Issuer:     CORCEPT THERAPEUTICS INC (CORT)
CIK:        0001088856
Form:       8-K
Filed at:   2025-06-16T23:59:59+00:00
Accession:  0001628280-25-031624
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Corcept shareholders elect nine directors, ratify Ernst & Young, approve executive comp at annual meeting
--------------------------------------------------------------------------------

- All nine director nominees elected with substantial support; David Mahoney received 62.7M for, 14.7M withheld.
- Ernst & Young ratified as auditor for FY 2025 with 90.5M votes for, 1.5M against.
- Advisory vote on executive compensation approved with 72.9M for, 4.2M against, 14.9M broker non-votes.
- Total shares voted: 92.3M out of 106.0M eligible shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1088856/000162828025031624/0001628280-25-031624-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1088856/000162828025031624/cort-20250610.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-031624

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer